MedPath

Management of migraine through Gandharyadi ghrita nasya and Goghrita nasya. A comparative study.

Phase 2
Not yet recruiting
Conditions
Mental Health,
Registration Number
CTRI/2020/04/024530
Brief Summary

Migraine is a complex  neurological  disorder  that  manifests with  recurrent headache, nausea, vomiting, photophobia or phonophobia. Theprevalence of migraine  is 15% to 20%  in women  and 4% to 7%  in men. In children the prevalence may be as high as 17% and isequal in boys and girls. The highest prevalence  occur between the  ages of  25yrs and  55 yrs. Based  on  sign and  symptoms  of  Ardhavabhedaka. It can be compared  with migraine. Objective of this study is to compare theefficacy of Gandharyadi ghrita nasya and Go ghrita nasya along with internalmedication as Narikela khanda in the management of *Ardhavabhedaka*. Study will conduct in AIIA hospital with taken 15patients in each groups by block randomization. Diagnosis of patient will bedone according Intrernational headache society for migraine. Primary assessmentparameter will pain and secondary will quality of life. Total duration of thisstudy will be 53days.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Patients having symptoms of Ardhavabhedaka , 1) Ardha parshwa Shirashoola– unilateral headache 2) Bheda , Toda, Shoola- pulsating , throbbing type of pain 3) Pakshat, Dashahat ,Akasmat- paroxysmal episodes.
    1. Prakasha Asahishnata- photophobia, Nausea (Hrillas), vomiting (Chardi).
    1. phonophobia.
Exclusion Criteria

Known cases of Secondary headache caused by sinusitis , meningitis , brain tumour, increased intra ocular pressure , malignant HTN.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Response in headacheAssesment will be done on baseline, 23day, 38day and 53day.
Secondary Outcome Measures
NameTimeMethod
Overall improvement in quality of life.assesment will be taken on baseline, on 23,38day and 53 day.

Trial Locations

Locations (1)

All india institute of Ayurveda

🇮🇳

West, DELHI, India

All india institute of Ayurveda
🇮🇳West, DELHI, India
Dr Santosh Kumar Bhatted
Principal investigator
8851939675
santoshbhatted@rediffmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.